Obata Taisuke, Matsumoto Kazuyuki, Harada Kei, Hattori Nao, Sato Ryosuke, Matsumi Akihiro, Miyamoto Kazuya, Terasawa Hiroyuki, Fujii Yuki, Uchida Daisuke, Horiguchi Shigeru, Tsutsumi Koichiro, Otsuka Motoyuki
Department of Gastroenterology and Hepatology, Okayama University Hospital, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
J Clin Med. 2025 May 13;14(10):3381. doi: 10.3390/jcm14103381.
: Endoscopic treatment is one of the first-line treatments for bile leaks after hepatic surgery. However, detailed reports of endoscopic treatment for bile leaks after hepatic resection (HR) or liver transplantation (LT) are scarce. The outcomes of endoscopic treatment for bile leaks after hepatic surgery were examined, and factors related to successful treatment were identified. : A total of 122 patients underwent endoscopic treatment for bile leaks after hepatic surgery. The diagnosis of a bile leak is based on the ISGLS criteria. The decision to perform endoscopic retrograde cholangiography (ERC) is made based on the amount of drainage output, laboratory data, clinical symptoms, and CT scan findings. In our study, the site of the bile leak was assessed using ERC. Endoscopic stents were placed to bridge across the bile leak site as much as possible. Otherwise, stents were placed near the leak site. Endoscopic stents were replaced every 2-3 months until an improvement in the bile leak was observed with or without biliary strictures. The outcomes of endoscopic treatment and the factors related to clinical success were evaluated. : Seventy-four patients with HR and forty-eight patients with LT were treated endoscopically. Technical and clinical success was achieved in 89% (109/122) and 82% (100/122) of patients, respectively. Three (2%) patients died from uncontrollable bile leaks. Bridging stent placement ( < 0.001), coexistent percutaneous drainage ( = 0.0025), and leak severity ( = 0.015) were identified as independent factors related to the clinical success of endoscopic treatment. During a median observation period of 1162 days after the achievement of clinical success, bile leak recurrence was observed in only three cases (3%). : Endoscopic treatment is safe and effective for bile leaks after hepatic surgery. Bridging stent placement across the leak site is the most crucial factor for clinical success.
内镜治疗是肝手术后胆漏的一线治疗方法之一。然而,关于肝切除(HR)或肝移植(LT)后胆漏内镜治疗的详细报道较少。本研究对肝手术后胆漏的内镜治疗结果进行了检查,并确定了与治疗成功相关的因素。
共有122例患者在肝手术后接受了胆漏的内镜治疗。胆漏的诊断基于国际肝脏手术研究组(ISGLS)标准。根据引流液量、实验室数据、临床症状和CT扫描结果决定是否进行内镜逆行胆管造影(ERC)。在本研究中,使用ERC评估胆漏部位。尽可能在内镜下放置支架跨越胆漏部位。否则,将支架放置在漏口附近。每2 - 3个月更换一次内镜支架,直至观察到胆漏改善,无论有无胆道狭窄。评估内镜治疗的结果以及与临床成功相关的因素。
74例HR患者和48例LT患者接受了内镜治疗。技术成功率和临床成功率分别为89%(109/122)和82%(100/122)。3例(2%)患者死于无法控制的胆漏。跨越支架置入(<0.001)、并存经皮引流(=0.0025)和漏口严重程度(=0.015)被确定为与内镜治疗临床成功相关的独立因素。在临床成功后的中位观察期1162天内,仅3例(3%)观察到胆漏复发。
内镜治疗肝手术后胆漏安全有效。跨越漏口部位放置支架是临床成功的最关键因素。